Publications by authors named "Michael Wittlinger"

Claim this Profile
L
Lessons learned after one year of COVID-19 from a urologist and radiotherapist view: A German survey on prostate cancer diagnosis and treatment.
Nina N Harke, Christian Wagner, Robert M Hermann, Boris A Hadaschik, Jan Philipp Radtke, Michael Wittlinger

PLoS One· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of TIP60 (tat-interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment-specific outcome of localised invasive bladder cancer.
Jens R Laurberg, Anne S Brems-Eskildsen, Iver Nordentoft, Niels Fristrup, Troels Schepeler, Michael Wittlinger

BJU Int· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quadrimodal treatment of high-risk T1 and T2 bladder cancer: transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia.
Michael Wittlinger, Claus M Rödel, Christian Weiss, Steffen F Krause, Reinhard Kühn

Radiother Oncol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survivin expression as a predictive marker for local control in patients with high-risk T1 bladder cancer treated with transurethral resection and radiochemotherapy.
Christian Weiss, Felix von Römer, Gianni Capalbo, Oliver J Ott, Michael Wittlinger

Int J Radiat Oncol Biol Phys· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma.
Dominik Pretscher, Luitpold V Distel, Gerhard G Grabenbauer, Michael Wittlinger, Maike Buettner

BMC Cancer· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment options for high-risk T1 bladder cancer: status quo and future perspectives of radiochemotherapy.
Christian Weiss, Oliver J Ott, Michael Wittlinger, Steffen F Krause, Rainer Fietkau

Strahlenther Onkol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapy.
Christian Weiss, Michael Wittlinger, Dirk G Engehausen, Frens S Krause, Oliver J Ott

Int J Radiat Oncol Biol Phys· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time and dose-dependent activation of p53 serine 15 phosphorylation among cell lines with different radiation sensitivity.
Michael Wittlinger, Gerhard G Grabenbauer, Carl N Sprung, Rolf Sauer, Luitpold V R Distel

Int J Radiat Biol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis